PromiseBio
Latest round
- Seed
Last raised
- Apr 2023
Total raised
- $8.3M
Investors
- 3
About PromiseBio
Based in Tel Aviv, Israel, and founded in 2023, PromiseBio is a biotechnology company that develops a virtual AI platform to identify Post-Translational Modifications in proteins. PromiseBio focuses on precision medicine for autoimmune diseases, using a cloud-based AI platform to analyze protein changes, specifically post-translational modifications (PTMs) that control protein activity. The company technology helps to understand disease mechanisms and identify biomarkers by using advanced algorithms and explainable AI. PromiseBio's solutions are mainly aimed at the biopharmaceutical industry, particularly companies involved in drug development and clinical trials in North America and Europe. The platform supports treatment selection, early response evaluation, and disease monitoring, with the goal of improving patient outcomes in autoimmune diseases.
Who invested in PromiseBio
3 investors across 1 round
See all investors in PromiseBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 1, 2023
Amount
$8.3M
Investors
Questions about PromiseBio
Who invested in PromiseBio?
PromiseBio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PromiseBio raised?
PromiseBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PromiseBio last raise money?
PromiseBio's most recent round on record is a Seed, in Apr 2023.
What does PromiseBio do?
Based in Tel Aviv, Israel, and founded in 2023, PromiseBio is a biotechnology company that develops a virtual AI platform to identify Post-Translational Modifications in proteins.
Where is PromiseBio headquartered?
PromiseBio is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like PromiseBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at PromiseBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like PromiseBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.